NASDAQ:DARE - Dare Bioscience Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Dare Bioscience Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.24 -0.03 (-2.36 %) (As of 01/28/2020 05:11 AM ET) Add Compare Today's Range$1.15Now: $1.24▼$1.2650-Day Range$0.80MA: $1.03▼$1.7052-Week Range$0.69Now: $1.24▼$3.25Volume1.11 million shsAverage Volume4.32 million shsMarket Capitalization$20.68 millionP/E RatioN/ADividend YieldN/ABeta1.86 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Daré Bioscience, Inc, a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product candidates include Ovaprene, a non-hormonal monthly contraceptive; and SST-6007, a topical sildenafil cream for female sexual arousal disorder. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DARE Previous Symbol CUSIPN/A CIK1401914 Webhttp://www.darebioscience.com/ Phone858-926-7655Debt Debt-to-Equity RatioN/A Current Ratio1.72 Quick Ratio1.72Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book2.10Profitability EPS (Most Recent Fiscal Year)($1.09) Net Income$-16,740,000.00 Net MarginsN/A Return on Equity-306.48% Return on Assets-222.29%Miscellaneous Employees5 Outstanding Shares16,680,000Market Cap$20.68 million Next Earnings Date4/6/2020 (Estimated) OptionableNot Optionable Receive DARE News and Ratings via Email Sign-up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:DARE Rates by TradingView Dare Bioscience (NASDAQ:DARE) Frequently Asked Questions What is Dare Bioscience's stock symbol? Dare Bioscience trades on the NASDAQ under the ticker symbol "DARE." How were Dare Bioscience's earnings last quarter? Dare Bioscience Inc (NASDAQ:DARE) released its quarterly earnings results on Thursday, November, 14th. The biotechnology company reported ($0.20) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.21) by $0.01. View Dare Bioscience's Earnings History. When is Dare Bioscience's next earnings date? Dare Bioscience is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Dare Bioscience. What price target have analysts set for DARE? 2 Wall Street analysts have issued 12-month target prices for Dare Bioscience's shares. Their forecasts range from $3.00 to $3.00. On average, they anticipate Dare Bioscience's stock price to reach $3.00 in the next year. This suggests a possible upside of 141.9% from the stock's current price. View Analyst Price Targets for Dare Bioscience. What is the consensus analysts' recommendation for Dare Bioscience? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dare Bioscience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dare Bioscience. Has Dare Bioscience been receiving favorable news coverage? Media stories about DARE stock have trended somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Dare Bioscience earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Dare Bioscience. Are investors shorting Dare Bioscience? Dare Bioscience saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 649,000 shares, an increase of 5.8% from the December 31st total of 613,500 shares. Based on an average trading volume of 1,260,000 shares, the short-interest ratio is presently 0.5 days. Currently, 3.9% of the company's stock are short sold. View Dare Bioscience's Current Options Chain. Who are some of Dare Bioscience's key competitors? Some companies that are related to Dare Bioscience include Immunic (IMUX), Catalyst Biosciences (CBIO), Infinity Pharmaceuticals (INFI), IMMUTEP LTD/S (IMMP), VERONA PHARMA P/S (VRNA), Cumberland Pharmaceuticals (CPIX), Chembio Diagnostics (CEMI), CTI BioPharma (CTIC), Checkpoint Therapeutics (CKPT), Catabasis Pharmaceuticals (CATB), ASLAN PHARMACEU/ADR (ASLN), CNS Pharmaceuticals (CNSP), Eyenovia (EYEN), Aridis Pharmaceuticals (ARDS) and Tiziana Life Sciences (TLSA). What other stocks do shareholders of Dare Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dare Bioscience investors own include FuelCell Energy (FCEL), BIOLINERX LTD/S (BLRX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Tonix Pharmaceuticals (TNXP), AEterna Zentaris (AEZS), AVEO Pharmaceuticals (AVEO), Catalyst Pharmaceuticals (CPRX), CytRx (CYTR) and Heat Biologics (HTBX). Who are Dare Bioscience's key executives? Dare Bioscience's management team includes the folowing people: Ms. Sabrina Martucci Johnson, Pres, CEO, Sec. & Director (Age 52)Ms. Lisa Walters-Hoffert, Chief Financial Officer (Age 60)Mr. Mark Walters, VP of Operations (Age 64)Ms. MarDee J. Haring-Layton, VP of Accounting & Fin. (Age 43)Dr. David Friend, Chief Scientific Officer Who are Dare Bioscience's major shareholders? Dare Bioscience's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Interwest Venture Management Co. (0.30%). View Institutional Ownership Trends for Dare Bioscience. Which institutional investors are buying Dare Bioscience stock? DARE stock was acquired by a variety of institutional investors in the last quarter, including Interwest Venture Management Co.. View Insider Buying and Selling for Dare Bioscience. How do I buy shares of Dare Bioscience? Shares of DARE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Dare Bioscience's stock price today? One share of DARE stock can currently be purchased for approximately $1.24. How big of a company is Dare Bioscience? Dare Bioscience has a market capitalization of $20.68 million. The biotechnology company earns $-16,740,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Dare Bioscience employs 5 workers across the globe.View Additional Information About Dare Bioscience. What is Dare Bioscience's official website? The official website for Dare Bioscience is http://www.darebioscience.com/. How can I contact Dare Bioscience? Dare Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at 858-926-7655 or via email at [email protected] MarketBeat Community Rating for Dare Bioscience (NASDAQ DARE)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 298 (Vote Outperform)Underperform Votes: 218 (Vote Underperform)Total Votes: 516MarketBeat's community ratings are surveys of what our community members think about Dare Bioscience and other stocks. Vote "Outperform" if you believe DARE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DARE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/28/2020 by MarketBeat.com StaffFeatured Article: What is a Swap?
